NOX4 and idiopathic pulmonary fibrosis: However, considerable variability in expression of NOX4 and in antioxidant gene expression, as observed in the present study, might explain why redox-targeted therapies have failed to be generally effective in IPF thus far, and may only be suitable for specific clusters of IPF patients instead [39].